Akums Drugs and Pharmaceuticals Cash Flow Annual

BSE: 544222 | NSE: AKUMS | ISIN: INE09XN01023 | Sector: Biotechnology & Drugs

727.50 +31.00 (4.45%)Updated : 10 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	49.93	-530.07	-64.58	164.98
Net Changein Cash	284.81	-9.86	59.44	-3.53
Cash Taxes Paid	87.37	81.24	62.42	97.06
Net Income/ Starting Line	382.10	345.25	-45.28	150.30
Changesin Working Capital	634.84	-47.77	-12.93	-131.40
Cashfrom Operating Activities	1,181.20	465.20	497.88	176.63
Cash Interest Paid	16.05	34.51	43.44	40.44
Cashfrom Financing Activities	33.88	72.79	-108.02	124.54
Issuance( Retirement)of Stock Net	0.00	637.37	-	-
Depreciation/ Depletion	154.55	153.45	125.64	112.81
Other Investing Cash Flow Items Total	-699.74	-275.53	-19.01	24.09
Capital Expenditures	-230.53	-272.31	-311.41	-328.79
period Type	-	-	-	-
Non- Cash Items	9.71	14.26	430.45	44.92
Financing Cash Flow Items	-16.05	-34.51	-43.44	-40.44
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-930.27	-547.84	-330.42	-304.70

*All figures in crores except per share values

Trending Stocks

5,098.20+155.20(3.14%)

1,102.85+20.85(1.93%)

2,024.95+23.05(1.15%)

1,072.00-24.05 (-2.19%)

310.50-4.95 (-1.57%)

Related News